Evidence map›Paper›PMID 32193509›Full record

Observational studyScientific reports2020

Double-Stranded DNA and NETs Components in Relation to Clinical Outcome After ST-Elevation Myocardial Infarction.

Miriam Sjåstad Langseth, Ragnhild Helseth, Vibeke Ritschel, Charlotte Holst Hansen, Geir Øystein Andersen, Jan Eritsland, Sigrun Halvorsen, Morten Wang Fagerland, Svein Solheim, Harald Arnesen and 2 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Quercetin is a potential therapy for post-infarction NETosis formation.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Exploring Neutrophil Extracellular Traps in Cardiovascular Pathologies: The Impact of Lipid Profiles, PAD4, and Radiation.Biocell : official journal of the Sociedades Latinoamericanas de Microscopia Electronica ... et. al · 2025
    Article
  18. Human vaccines & immunotherapeutics · 2024
    Article
  19. Neutrophil extracellular traps: a catalyst for atherosclerosis.Molecular and cellular biochemistry · 2024
    Review
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Miriam Sjåstad LangsethCenter for Clinical Heart Research, Oslo University Hospital Ullevål, PB 4956 Nydalen, 0424, Oslo, Norway. m.s.langseth@studmed.uio.no.
Ragnhild HelsethCenter for Clinical Heart Research, Oslo University Hospital Ullevål, PB 4956 Nydalen, 0424, Oslo, Norway.
Vibeke RitschelCenter for Clinical Heart Research, Oslo University Hospital Ullevål, PB 4956 Nydalen, 0424, Oslo, Norway.
Charlotte Holst HansenCenter for Clinical Heart Research, Oslo University Hospital Ullevål, PB 4956 Nydalen, 0424, Oslo, Norway.
Geir Øystein AndersenCenter for Clinical Heart Research, Oslo University Hospital Ullevål, PB 4956 Nydalen, 0424, Oslo, Norway.
Jan EritslandCenter for Clinical Heart Research, Oslo University Hospital Ullevål, PB 4956 Nydalen, 0424, Oslo, Norway.
Sigrun HalvorsenFaculty of Medicine, University of Oslo, PB 1078 Blindern, 0316, Oslo, Norway.
Morten Wang FagerlandOslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, PB 4950 Nydalen, 0424, Oslo, Norway.
Svein SolheimCenter for Clinical Heart Research, Oslo University Hospital Ullevål, PB 4956 Nydalen, 0424, Oslo, Norway.
Harald ArnesenCenter for Clinical Heart Research, Oslo University Hospital Ullevål, PB 4956 Nydalen, 0424, Oslo, Norway.
Ingebjørg SeljeflotCenter for Clinical Heart Research, Oslo University Hospital Ullevål, PB 4956 Nydalen, 0424, Oslo, Norway.
Trine Baur OpstadCenter for Clinical Heart Research, Oslo University Hospital Ullevål, PB 4956 Nydalen, 0424, Oslo, Norway.
Oslo University Hospital · NOUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neutrophil extracellular traps (NETs) have been implicated in atherothrombosis; however, their potential role as markers of risk is unclear. We investigated whether circulating NETs-related components associated with clinical outcome and hypercoagulability in ST-elevation myocardial infarction (STEMI). In this observational cohort study, STEMI patients admitted for PCI (n = 956) were followed for median 4.6 years, recording 190 events (reinfarction, unscheduled revascularization, stroke, heart failure hospitalization, or death). Serum drawn median 18 hours post-PCI was used to quantify double-stranded DNA (dsDNA) and the more specific NETs markers myeloperoxidase-DNA and citrullinated histone 3. Levels of the NETs markers did not differ significantly between groups with/without a primary composite endpoint. However, patients who died (n = 76) had higher dsDNA compared to survivors (p < 0.001). Above-median dsDNA was associated with an increased number of deaths (54 vs. 22, p < 0.001). dsDNA in the upper quartiles (Q) was associated with increased mortality (Q3 vs. Q1 + 2 adjusted HR: 1.89 [95% CI 1.03 to 3.49], p = 0.041 and Q4 vs. Q1 + 2 adjusted HR: 2.28 [95% CI 1.19 to 4.36], p = 0.013). dsDNA was weakly correlated with D-dimer (r

Indexed as

DNAElectrocardiographyLeukocyte CountAdultAgedAged, 80 and overBiomarkersCohort StudiesFemaleHumansMaleMiddle AgedMyocardial InfarctionPercutaneous Coronary InterventionPeroxidasePrognosisBiomarkersDNAPeroxidase

Identifiers

PMID32193509
PMCPMC7081350
OpenAlexW3012551220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.